Skip to main content
. Author manuscript; available in PMC: 2008 Nov 25.
Published in final edited form as: Leuk Res. 2008 Jan 7;32(9):1458–1461. doi: 10.1016/j.leukres.2007.11.030

Figure 2. Clinical Outcomes by B-cell Count.

Figure 2

Figure 2

Figure 2A: Time to treatment curve for patients with Rai stage 0 CLL at diagnosis (NCI 1996 criteria) based on absolute B-cell count <5.0 × 109/L (n=47) vs. B-cell count ≥5.0 × 109/L (n=65)

Figure 2B: OS curve for patients with Rai stage 0 CLL at diagnosis (NCI 1996 criteria) based on absolute B-cell count <5.0 × 109/L (n=47) vs B-cell count ≥5.0 × 109/L (n=65)